Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended

Recent studies demonstrate that early molecular response to tyrosine-kinase inhibitors is strongly predictive of outcome in chronic myeloid leukemia patients and that early response landmarks may identify patients at higher risk for transformation who would benefit from an early switch to second-lin...

Full description

Saved in:
Bibliographic Details
Main Authors: Huet, Sarah, Cony-Makhoul, Pascale, Heiblig, Maël, Tigaud, Isabelle, Gazzo, Sophie, Belhabri, Amine, Souche, Denis, Michallet, Mauricette, Magaud, Jean-Pierre, Hayette, Sandrine, Nicolini, Franck
Format: Artigo
Language:Inglês
Published: Public Library of Science 2014
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4159116/
https://ncbi.nlm.nih.gov/pubmed/25203717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0106250
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items